Articles tagged "Graft survival"

2015 American Transplant Congress
Early Steroid Withdrawal and Calcineurin Inhibitor Minimization Protocols for Maintenance Immunosuppression: A Single Center 10-Year Experience
R. Lopez-Soler,¹ L. Park,³ J. Martinolich,² D. Conti.¹
¹Transplant Surgery, Albany Medical Center, Albany, NY; ²Surgery, Albany Medical Center, Albany, NY; ³Albany School of Medicine, Albany, NY.
BACKGROUND:Long term use of steroids results in predictable secondary effects that can lead to increased morbidity and mortality. Additionally, long term high levels of Calcineurin…
2015 American Transplant Congress
Part II: Rates and Determinants of Progression for De Novo Donor-Specific Antibody Mediated Kidney Allograft Injury
C. Wiebe,^1,2 I. Gibson,³ D. Pochinco,² P. Birk,⁴ T. Blydt-Hansen,⁴ J. Ho,^1,5 M. Karpinski,¹ A. Goldberg,⁴ L. Storsley,¹ D. Rush,¹ P. Nickerson.^1,2,5
¹Medicine, University of Manitoba, Winnipeg, MB, Canada; ²Immunogenetics, Diagnostic Services of Manitoba, Winnipeg, MB, Canada; ³Pathology, University of Manitoba, Winnipeg, MB, Canada; ⁴Pediatric and Child Health, University of Manitoba, Winnipeg, MB, Canada; ⁵Immunology, University of Manitoba, Winnipeg, MB, Canada.
The development of de novo donor-specific antibody (dnDSA) is an independent predictor of allograft loss in renal transplantation. Rates and determinants of clinical pathologic progression…
2015 American Transplant Congress
Risk Associated With DCD Kidney Transplantation Varies by Donor Characteristics
X. Luo, A. Massie, E. Chow, D. Segev.
Johns Hopkins, Baltimore.
Studies have shown that comparable kidney graft survival between donors after brain death (DBD) and donors after circulatory death (DCD) overall. However, the differential risk…
2015 American Transplant Congress
Impact of Delayed Graft Function and Number of Dialysis Sessions on Graft Outcome After Kidney Transplantation
L. Lehner, A. Hohberger, L. Marschke, K. Zhang, F. Halleck, D. Khadzhynov, O. Staeck, M. Dürr, D. Schmidt, L. Liefeldt, K. Budde.
Dep.of Nephrology Charité Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany.
IntroductionDelayed graft function (DGF), defined as dialysis within the first week after kidney transplantation, is a common and known risk factor for impaired renal graft…
2015 American Transplant Congress
Outcomes of Treatment of Late Antibody-Mediated Rejection in Primary Renal Transplant Recipients – A Single Center Experience
R. Prashar, A. Patel, K. Venkat.
Division of Nephrology and Transplant Institute, Henry Ford Hospital, Detroit, MI.
Background: Successful reversal of early post-transplant antibody mediated rejection (AMR) is well documented, but data on the results of treatment of late AMR are lacking.…
2015 American Transplant Congress
Six-Month Urinary CCL2 Levels Predict Long-Term Renal Allograft Outcome
J. Ho,¹ D. Rush,¹ A. Gao,¹ H. Hopfer,² C. Wiebe,¹ P. Nickerson,¹ S. Schaub,² P. Hirt-Minkowski.²
¹Internal Medicine, Nephrology, University of Manitoba, Winnipeg, MB, Canada; ²Transplantation Immunology & Nephrology, University Hospital, Basel, Basel, Switzerland.
Graft loss is a major cause of morbidity and mortality. We have shown that 6-month urine CCL2 is an independent predictor for death-censored graft loss.…
2015 American Transplant Congress
Recreational Marijuana Use Is Not Associated With Worse Kidney Allograft Outcomes
G. Greenan, M. Anders, A. Leeser, J. Bromberg, S. Niederhaus.
Department of Surgery, University of Maryland, Baltimore, MD; Department of Anesthesiology, University of Maryland, Baltimore, MD; Department of Surgery, University of Maryland, Baltimore, MD; Department of Surgery, University of Maryland, Baltimore, MD; Department of Surgery, University of Maryland, Baltimore, MD.
Background: As marijuana (MJ) legalization is ongoing, kidney transplant programs need to develop listing criteria for MJ users. No data exist on whether recreational MJ…
2015 American Transplant Congress
The Potential of E-Health to Improve Adherence: Exploring the Patients' View
D. Slaats,¹ M. Tielen,¹ M. Laging,¹ T. van Gelder,² W. Weimar,¹ E. Massey.¹
¹Internal Medicine, Erasmus MC, Rotterdam, Netherlands; ²Internal Medicine and Hospital Pharmacology, Erasmus MC, Rotterdam, Netherlands.
Introduction. Transplant outcomes can be negatively influenced by medication nonadherence. Therefore, there is a need for effective interventions to improve adherence. In recent years due…
2015 American Transplant Congress
Calcineurin-Inhibitor Conversion to mTOR Inhibitor in Renal Transplant Recipients Leads to Worse Long Term Clinical Outcomes
A. Alvarado,¹ A. Shetty,¹ O. Traitanon,¹ J. Leventhal,¹ V. Mas,² D. Chhabra,³ J. Matthews,¹ L. Gallon.¹
¹Comprehensive Transplant Center, Northwestern University, Chicago, IL; ²University of Virgina, Charlottesville, Va; ³Advocate Christ Medical Center, Chicago, IL.
We previously reported the short-term feasibility of Calcineurin-Inhibitor (CNI) elimination in kidney transplant recipients. We now report the long-term clinical impact on renal allograft function…
2015 American Transplant Congress
Transplanting Pediatric Livers Into Adult Recipients Is Associated With Increased Rejection and Decreased Survival
V. Fleetwood, J. Harris, M. Hertl, E. Chan.
General Surgery, Division of Transplantation, Rush University Medical Center, Chicago, IL.
Introduction: Transplantation of pediatric livers to adult recipients, a measure which places the graft at higher risk of hepatic artery thrombosis (HA), is frequently necessitated…